4D Molecular Therapeutics, Inc. Employee Count
The employee counts 4D Molecular Therapeutics, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 196; Filing 2026-03-18; Lease expense per employee $41,525.51.
- 2024-12-31: Employees (as filed) 227; Filing 2025-02-28; Lease expense per employee $24,339.21.
- 2023-12-31: Employees (as filed) 147; Filing 2024-02-29; Lease expense per employee $27,462.59.
- 2022-12-31: Employees (as filed) 140; Filing 2023-03-15; Lease expense per employee $27,121.43.
- Available history
- 2021-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 196 full-time | 2026-03-18 | $41,525.51 total lease cost |
| 2024-12-31 | 227 full-time | 2025-02-28 | $24,339.21 total lease cost |
| 2023-12-31 | 147 full-time | 2024-02-29 | $27,462.59 total lease cost |
| 2022-12-31 | 140 full-time | 2023-03-15 | $27,121.43 total lease cost |
| 2021-12-31 | 124 full-time | 2022-03-28 | $28,588.71 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Entera Bio Ltd. (ENTX) | $0.485B |